Home
Investment
News & Views
Company News
news storage
Broker snap: Nyomed deal to boost revenues
Wed, 08 Feb, 2012
INVESTMENT NEWS
Company Search
Search QCK.COM
Investment Home
News & Views
Top Stories
Charting
Company Search
Watchlist
Market Reports
Market Buzz
Company News
Economic News
New Issues
Other News
Broker snap: Nyomed deal to boost revenues
Tue, 31 Aug 2010, 08:33:00
Daniel Stewart has upped its current year product revenues forecast for <b>BTG</b> after the specialty pharmaceuticals company signed another agreement with US outfit Nyomed. Under the terms of the agreement BTG will gain access to Nycomed's market data, customers and sales force, and from 1 October 2010 BTG will have exclusive rights to market and sell the products. In return, BTG will pay Nycomed up to £10.3m, the precise amount depending on the amount of product delivered to and sold by Nycomed before 30 September 2010. Daniel Stewart's educated guess is that the final amount will be £9m. "As a result of this agreement, we now anticipate that product revenues for the current financial year will be £9m higher than previously forecast (£97m vs. £88m previously)," said Daniel Stewart analyst Vadim Alexandre. "The increase in revenue is expected to flow directly into gross profit, as full manufacturing costs have already been included in BTG's expectations," Vadim observed.
©2004-2009 QCK.com
